Skip to main content
Your session has expired. Reloading...
Cardiovascular

ApoA1 Blood Test

ApoA1 measures HDL's protective function, which becomes increasingly important for cardiovascular health as you age. Regular monitoring supports heart disease prevention.

Doctor's Assessment Included

Reference Ranges

See the value that applies to you:

Choose male or female — this range differs by sex.

Enter your age — this range changes with age.

This range also depends on context such as cycle phase or sample material; the highlighted rows apply to your group.

Male Your group
g/l
Low 1.04 Normal 2.02 High
Female Your group
g/l
Low 1.08 Normal 2.25 High

Source: Roche Diagnostics (Tina-quant apoA1), gepubliceerd door Newcastle upon Tyne Hospitals NHS Foundation Trust Reference population: Adults; Roche Tina-quant apoA1 assay

Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.

Check your own value

ApoA1 (Apolipoprotein A1): what this test measures

This test measures the level of ApoA1 protein in your blood. It provides a direct measure of the functional component of HDL cholesterol.

ApoA1 (Apolipoprotein A1): why this value matters

Higher ApoA1 levels are generally associated with lower cardiovascular risk. ApoA1 may provide a more accurate cardiovascular risk assessment than HDL cholesterol alone. Consult your healthcare provider.

ApoA1 (Apolipoprotein A1): how the blood test works

Referral
No GP referral needed. After the order we arrange the referral through ZorgDomein, within one business day; orders after 17:00 or at the weekend start on the next business day. ZorgDomein emails a barcode, and that barcode is what the draw site needs.
The draw
A blood draw from a vein in the arm, at a partner laboratory's draw site. No home kit, no finger prick.
Which test
on its own €49,-
Where
650+ draw sites run by independent laboratories across the Netherlands. Draw sites

ApoA1 (Apolipoprotein A1): when is testing worthwhile?

Testing may be recommended as part of advanced cardiovascular risk assessment, especially when standard lipid panels are inconclusive or when there is a family history of heart disease.

ApoA1 (Apolipoprotein A1): symptoms of a high or low value

Low Levels

Low ApoA1 may be associated with increased cardiovascular risk. There are typically no direct symptoms, but it suggests reduced cholesterol clearance from arteries.

High Levels

High ApoA1 levels are generally considered protective and are not associated with adverse symptoms.

ApoA1 (Apolipoprotein A1): lifestyle and this value

Regular aerobic exercise, moderate alcohol consumption, omega-3 fatty acids, and a diet rich in healthy fats can support healthy ApoA1 levels. Avoiding smoking and maintaining a healthy weight also help.

ApoA1 (Apolipoprotein A1): frequently asked questions

How is ApoA1 different from HDL cholesterol?

HDL cholesterol measures the cholesterol carried by HDL particles, while ApoA1 measures the protein that makes HDL functional. ApoA1 may better reflect cardiovascular protection.

What is the ApoB/ApoA1 ratio?

This ratio compares atherogenic to protective lipoproteins and may be a powerful predictor of cardiovascular risk. Your healthcare provider can explain what your ratio means.

Can exercise increase ApoA1?

Yes, regular aerobic exercise is one of the most effective ways to raise ApoA1 and HDL levels.

ApoA1 (Apolipoprotein A1): sources

  1. Newcastle upon Tyne Hospitals NHS — Apolipoprotein A1 (serum) test directory: "Men: 1.04-2.02 g/L / Women: 1.08-2.25 g/L" (Roche Tina-quant immunoturbidimetrisch assay). Leeds Teaching Hospitals reprint dezelfde waarden en verwijzen apoA1 naar Newcastle RVI. Deze waarden komen overeen met de referentie-intervallen die ons laboratorium op echte apoA1-uitslagen doorgeeft (zie dossiers/riu-07.md). Ter onderbouwing van de envelop: Nederlandse ziekenhuislaboratoria Franciscus Gasthuis en Slingeland publiceren M 1,10-2,05 / V 1,25-2,15 g/l, en de Finse populatiestudie FINRISK 2007 (PMID 21419755) M 1,1-2,0 / V 1,2-2,3 g/l. Geraadpleegd 15 juli 2026. (retrieved 2026) laboratories.newcastle-hospitals.nhs.uk

Tests with related values

These panels measure values from the same category as this marker.

Heart & Metabolism

GLP-1 Baseline Panel

Your starting point before the first injection: blood sugar, cholesterol, pancreas, liver, kidneys, thyroid and nutrients in one measurement.

Insulin (Fasting) ALT (Alanine Aminotransferase) TSH (Thyroid Stimulating Hormone) AST (Aspartate Aminotransferase) HDL Cholesterol HbA1c (Glycated Hemoglobin) Bilirubin (Total) ApoB (Apolipoprotein B) Vitamin B12 Ferritin Potassium Sodium Glucose (Fasting) Total Cholesterol Albumin Lipase Creatinine Vitamin D (25-OH) Triglycerides Bilirubin (Direct) Bilirubin (Indirect) HOMA-IR eGFR (Estimated Glomerular Filtration Rate) LDL Cholesterol Cholesterol/HDL Ratio Non-HDL Cholesterol LDL/HDL Ratio
€214,-
Heart & Metabolism

GLP-1 Extended Panel

The 6-month measurement: everything from the check-in plus insulin, ApoB and your nutrients — especially relevant if you have been eating much less for a while.

Insulin (Fasting) ALT (Alanine Aminotransferase) AST (Aspartate Aminotransferase) HDL Cholesterol HbA1c (Glycated Hemoglobin) ApoB (Apolipoprotein B) Vitamin B12 Ferritin Potassium Sodium Glucose (Fasting) Total Cholesterol Albumin Lipase Creatinine Vitamin D (25-OH) Triglycerides HOMA-IR eGFR (Estimated Glomerular Filtration Rate) LDL Cholesterol Cholesterol/HDL Ratio Non-HDL Cholesterol LDL/HDL Ratio
€196,-
Heart & Metabolism

GLP-1 Check-in Panel

The 3-month safety and progress check clinics do: pancreas, liver, kidneys, salts and your metabolic progress on GLP-1 medication.

ALT (Alanine Aminotransferase) AST (Aspartate Aminotransferase) HDL Cholesterol HbA1c (Glycated Hemoglobin) Potassium Sodium Glucose (Fasting) Total Cholesterol Lipase Creatinine Triglycerides eGFR (Estimated Glomerular Filtration Rate) LDL Cholesterol Cholesterol/HDL Ratio Non-HDL Cholesterol LDL/HDL Ratio
€109,-

Medical reviewer

Medical standards

Dr. Naimi oversees the medical standards behind our content and assessments.

Medical policy
CIBG Ministerie van Volksgezondheid,
Welzijn en Sport Official BIG registration BIG 49928676701 Opens in a new tab

ApoA1 (Apolipoprotein A1)

€49,-